Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (191-200 of 350) with videos related to

Pageof 35
Sort By:
United European Gastroenterology Journal|March 28, 2020
Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascitesMarie Schultalbers, Tammo L Tergast, Nicolas Simon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis EJana Al-Ayoubi, Patrick Behrendt, Birgit Bremer, et al.
Frontiers in Public Health|October 5, 2020
Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping ReviewIda Sperle, Gyde Steffen, Siv Aina Leendertz, et al.
Journal of Hepatology|August 19, 2014
A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis CSolomon Owusu Sekyere, Pothakamuri Venkata Suneetha, Anke Renate Maria Kraft, et al.
Antiviral Therapy|September 9, 2011
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analoguesJerzy Jaroszewicz, Huy Ho, Antoaneta Markova, et al.
Plos Pathogens|June 1, 2011
Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cellsVerena Schlaphoff, Sebastian Lunemann, Pothakamuri Venkata Suneetha, et al.
Plos Pathogens|April 27, 2012
Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitopeAlex T Chen, Markus Cornberg, Stephanie Gras, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 1, 2021
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter studyEvelyn Stelzl, Sandra Ciesek, Markus Cornberg, et al.
Hepatology Communications|June 6, 2022
Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-RegistryFrank Tacke, Hartwig Klinker, Klaus H W Boeker, et al.
Hepatology (Baltimore, Md.)|January 28, 2006
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II studyJohannes Wiegand, Peter Buggisch, Wulf Boecher, et al.
Pageof 35

Showing results (191-200 of 350) with videos related to

Sort By:
Pageof 35
United European Gastroenterology Journal|March 28, 2020
Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascitesMarie Schultalbers, Tammo L Tergast, Nicolas Simon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis EJana Al-Ayoubi, Patrick Behrendt, Birgit Bremer, et al.
Frontiers in Public Health|October 5, 2020
Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping ReviewIda Sperle, Gyde Steffen, Siv Aina Leendertz, et al.
Journal of Hepatology|August 19, 2014
A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis CSolomon Owusu Sekyere, Pothakamuri Venkata Suneetha, Anke Renate Maria Kraft, et al.
Antiviral Therapy|September 9, 2011
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analoguesJerzy Jaroszewicz, Huy Ho, Antoaneta Markova, et al.
Plos Pathogens|June 1, 2011
Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cellsVerena Schlaphoff, Sebastian Lunemann, Pothakamuri Venkata Suneetha, et al.
Plos Pathogens|April 27, 2012
Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitopeAlex T Chen, Markus Cornberg, Stephanie Gras, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 1, 2021
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter studyEvelyn Stelzl, Sandra Ciesek, Markus Cornberg, et al.
Hepatology Communications|June 6, 2022
Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-RegistryFrank Tacke, Hartwig Klinker, Klaus H W Boeker, et al.
Hepatology (Baltimore, Md.)|January 28, 2006
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II studyJohannes Wiegand, Peter Buggisch, Wulf Boecher, et al.
Pageof 35